Non-specific Effects of a Modified Measles Vaccination Schedule to Prevent Allergy and Unrelated Infection in Children
Trial statusRecruiting
Trial phasePhase 4
Trial typeInterventional
Biological sexAll
Age6-6
SponsorLaure Pittet, MD-PhD
About this trial
The goal of this clinical trial is to evaluate the off-target/non-specific effects of the measles-mumps-rubella (MMR) vaccine in children.
Eligibility criteria
Qualifiers
Informed Consent as documented by signature
6-month-old children
In overall good health, without any clinically significant concomitant disease states (e.g., renal failure, hepatic dysfunction, cardiovascular disease, etc.) and no clinically significant abnormal finding on history and/or physical examination
Fully immunised for age according to the Swiss vaccination schedule
Disqualifiers
Contra-indications to MMR, including
immunosuppression (i.e. proven, suspected, or planned)
allergy to a component of the vaccine
receipt of a live-attenuated vaccine in the four weeks prior to inclusion
Trial design
Treatments tested in this trial
- Measles-Mumps-Rubella vaccine (MMR)
Treatment groups
500 Participants
are divided into 4 treatment groupsSponsors and collaborators
Laure Pittet, MD-PhD
Lead sponsor
Pediatric Clinical Research Platform
Sponsor institution
Source ClinicalTrials.gov